5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Eris Lifesciences Ltd.

•
eris.co.inBSE: 540596NSE: ERIS
Market Cap₹ 18,506 Cr.
Current Price
High / Low₹ 1,745 / 1,200
Stock P/E96.2
Book Value₹ 233
Price to Book5.65
Dividend Yield0.00 %
ROCE10.8 %
ROE8.6 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.58x)
  • Working capital cycle has improved - days down from -77 to -139

CONS

  • Recent results are weak - TTM profit is down 42.2% versus prior year
  • Receivables are growing faster than sales - a possible quality concern
  • A large part of profit comes from other income (31.0% of PBT)
  • Company has a low return on capital employed of 9.3%
  • Company has a low return on equity of 8.1% over last 3 years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY TOTAL MKTNIFTY 500NIFTY SMLCAP 250
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.ERIS1335.3528.7418505.720.00143.3214.56873.2513.1814.4733.88
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
404402316332449429390396568638307268444
256265250262333294300284362354238256406
Operating Profit149137667011613590112206284691238
OPM %36.73%34.07%20.88%21.17%25.79%31.44%23.04%28.28%36.20%44.54%22.44%4.48%8.50%
47320568172324102726
Interest771529565655534546454342
Depreciation20252829464647433839393940
Profit before Tax133120354227466411562354-3364
Tax %16.43%1.76%8.63%5.37%36.47%38.94%70.48%26.01%36.01%36.26%20.57%73.76%24.70%
Net Profit111118324017282301001503-948
8.148.662.332.901.252.060.132.247.3410.980.23-0.633.49

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
7137618971,0201,1091,2161,3311,4871,6981,8221,656
4424455636656917328261,0331,2111,2231,253
Operating Profit271316334355417484505454487598403
OPM %38.04%41.54%37.23%34.79%37.65%39.82%37.96%30.53%28.66%32.85%24.31%
2528321510291735369787
Interest110232132157220180177
Depreciation21223245385165102182154157
Profit before Tax274312312324389459437329120362270
Tax %9.43%5.85%8.47%9.99%9.85%9.02%8.90%8.86%35.54%32.59%28.74%
Net Profit24829428529135141739830077244192
EPS18.0521.3620.7421.2125.8030.7029.2322.045.6817.62—
Dividend Payout %0.00%0.00%0.00%13.38%21.30%19.58%25.11%0.00%129.35%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
10%
3 Years:
11%

COMPOUNDED PROFIT GROWTH

10 Years:
6%
5 Years:
-7%
3 Years:
-15%

STOCK PRICE CAGR

10 Years:
—
5 Years:
12%
3 Years:
18%
1 Year:
-21%

RETURN ON EQUITY

10 Years:
24%
5 Years:
13%
3 Years:
8%
Last Year:
9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

May 29

₹ 7.21

Rs.7.2100 per share(721%)Interim Dividend

2025

Feb 13

₹ 7.35

Interim Dividend

2022

Aug 11

₹ 7.35

Interim Dividend

2021

Aug 5

₹ 6.01

Interim Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital14141414141414141414
5618541,1411,2831,5581,9032,2052,5052,4913,167
103791831113423092,3482,0121,260
Trade Payables25797590879783110216219
5616-11-25-45-57-24130223897
Total Liabilities6661,3421,4021,3731,6261,9982,5885,1074,9565,557
924904846015846428981,5162,4122,353
Capital Work in Progress0010000000
3815465803205317789971,6199911,414
4758756565856492191121
0000000240236307
Cash & Bank296653346481,2979228
1442412563214134475823441,0331,334
Total Assets6661,3421,4021,3731,6261,9982,5885,1074,9565,557

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
262304286316463452400336702564
Cash from Investing-199-5932127-348-268-513-2,492-359-694
Cash from Financing-18363-221-334-81-881942,160-31071
-67-258-34133432-59

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.8854.8754.8654.8554.8354.8554.8553.9254.14
14.598.008.368.438.397.216.856.395.76
16.2318.6418.0718.0718.1819.3620.3120.3520.71
Government0.000.000.000.000.000.000.000.000.00
14.3018.4718.7218.6618.5918.5717.9919.3319.40

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
Rumour Verification - Regulation 30(11)

2026-09-10 - Eris Lifesciences Limited has informed the Exchange about Rumour Verification - Regulation 30(11)

2026-09-09
Agreements

2026-09-09 - Eris Lifesciences Limited has informed the Exchange about Loan Agreement

2026-09-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-07 - Eris Lifesciences Limited has informed the Exchange about Schedule of meet

2026-09-03
Copy of Newspaper Publication

2026-09-03 - Eris Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02
Copy of Newspaper Publication

2026-09-02 - Eris Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-02
Shareholders meeting

2026-09-02 - Eris Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026

2026-08-31
Outcome of Board Meeting

2026-08-31 - Eris Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2026.

2026-08-24
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-24 - Eris Lifesciences Limited has informed the Exchange about Schedule of meet

2026-08-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-12 - Eris Lifesciences Limited has informed the Exchange about Schedule of meet

News

Recent coverage and analyst commentary for ERIS

Loading news…

🤖

AI Stock Analyst

Eris Lifesciences Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login